TGFB1 and hydrops fetalis: In the present study, the antifibrotic properties of the TGF-β1 inhibitor LY2157299 (GLY), encapsulated in polymeric nanomicelles, were investigated in a rat model of CCl4-induced HF and compared with the effects of the administration of a free drug in the same HF animal model.